Li Sarah 4
4 · InMed Pharmaceuticals Inc. · Filed Dec 19, 2022
Insider Transaction Report
Form 4
Li Sarah
VP, Accounting and Controller
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-12-16+3,600→ 4,002 totalExercise: $1.78Exp: 2027-12-15→ Common shares (3,600 underlying)
Footnotes (1)
- [F1]The options were granted on 12/16/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.